Markets:

Overview

News

Currencies

International

Treasuries

State Street SPDR S&P Biotech ETF (NY:XBI)

122.36 +0.69 (+0.57%)

Streaming Delayed Price Updated: 2:02 PM EST, Dec 31, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about State Street SPDR S&P Biotech ETF

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

Large Cap Biopharma Stocks provide Growth and Value ↗

August 16, 2021

The S&P 500 Healthcare Index was up 0.53% and biotech still lags in healthcare yet Large Cap Biopharma is doing well YTD.

Via Talk Markets

Topics Stocks

Analyzing SPDR Series Trust SPDR S&P Biotech ETF's Unusual Options Activity ↗

August 11, 2021

SPDR Series Trust SPDR S&P Biotech ETF (NYSE:XBI) shares...

Via Benzinga

Topics Stocks

Analyzing SPDR Series Trust SPDR S&P Biotech ETF's Unusual Options Activity ↗

August 09, 2021

SPDR Series Trust SPDR S&P Biotech ETF (NYSE:XBI) shares...

Via Benzinga

Topics Stocks

ETF Investing Areas to Consider for August ↗

August 09, 2021

There is no doubt that the second-quarter 2021 earnings season is going strong.

Via Talk Markets

Carter Worth And Mike Khouw's XBI Trade ↗

August 08, 2021

On CNBC's "Options Action," Carter Worth of Cornerstone Macro said SPDR S&P Biotech ETF (NYSE: XBI) has a bounce potential, having sold off to support. XBI is an...

Via Benzinga

Topics Stocks

Unusual Options Activity Insight: SPDR Series Trust SPDR S&P Biotech ETF ↗

August 06, 2021

On Friday, shares of SPDR Series Trust SPDR S&P Biotech ETF (NYSE:

Via Benzinga

Topics Stocks

Understanding SPDR Series Trust SPDR S&P Biotech ETF's Unusual Options Activity ↗

August 03, 2021

Shares of SPDR Series Trust SPDR S&P Biotech ETF (NYSE:XBI

Via Benzinga

Topics Stocks

Unusual Options Activity Insight: SPDR Series Trust SPDR S&P Biotech ETF ↗

July 30, 2021

SPDR Series Trust SPDR S&P Biotech ETF (NYSE:XBI) shares...

Via Benzinga

Topics Stocks

A Fresh Dose of Biotech Perspective ↗

May 30, 2021

If the only thing that’s changed with your favorite biotech is the price, stay the course. Your bottom line will thank you for it later.

Via Talk Markets

Analyzing SPDR Series Trust SPDR S&P Biotech ETF's Unusual Options Activity ↗

July 27, 2021

Analyzing SPDR Series Trust SPDR S&P Biotech ETF's Unusual Options Activity Shares of SPDR Series Trust SPDR S&P Biotech ETF (NYSE: XBI) saw some unusual options activity...

Via Benzinga

Topics Stocks

Analyzing SPDR Series Trust SPDR S&P Biotech ETF's Unusual Options Activity ↗

July 15, 2021

On Thursday, shares of SPDR Series Trust SPDR S&P Biotech ETF (NYSE:XBI) saw unusual options activity. After the option alert, the stock price moved up to $126.24. Sentiment...

Via Benzinga

Topics Stocks

Understanding SPDR Series Trust SPDR S&P Biotech ETF's Unusual Options Activity ↗

July 12, 2021

Shares of SPDR Series Trust SPDR S&P Biotech ETF (NYSE:XBI) saw some unusual options activity on Monday. Following the unusual option alert, the stock price moved down to $132...

Via Benzinga

Topics Stocks

Mid-Cap Biotech Picks: Seasonal Rally Underway ↗

July 03, 2021

Many Mid-Cap biotech stocks were hit hard after the February peak. We suggest three new mid-cap biotech picks. All three picks can be volatile but very tradable.

Via Talk Markets

IBB Vs. XBI: Which Biotech ETF Has A Better Chart? ↗

June 30, 2021

The SPDR S&P Biotech ETF XBI is trading below an important resistance level, but the iShares Nasdaq Biotechnology ETF IBB has broken out.

Via Talk Markets

Topics Stocks

IBB Vs. XBI: Which Biotech ETF Has A Better Chart? ↗

June 30, 2021

The SPDR S&P Biotech ETF (NYSE: XBI) is trading below an important resistance level, but the iShares Nasdaq Biotechnology ETF (NASDAQ: IBB) has broken out. Resistance is a...

Via Benzinga

Topics Stocks

Why Regeneron Pharmaceuticals Analyst Says Competitive Concerns Are Overblown, Pipeline Opportunity Underappreciated ↗

June 29, 2021

Regeneron Pharmaceuticals Inc.'s (NASDAQ:REGN) robust ...

Via Benzinga

Healthcare Portfolio Playbook: Time To Rebalance With MedTech ↗

June 18, 2021

As we look to re-balance our portfolio in the near-term, investors should consider adding Medtech as we have suggested in the past. Though, more recently, we have also focused on large-cap...

Via Talk Markets

Should You Buy Biotech ETFs Now? ↗

June 16, 2021

Instead of trying to pick winners in this volatile space, it is better to invest in broader biotech ETFs that stand to benefit from increased investor interest and rising spending on drugs and...

Via Talk Markets

Tuesday Talk: Action! ↗

June 15, 2021

U.S. stock markets started the week in continued action mode. The S&P 500 closed at 4,255, up nearly 8 points, the Dow closed at 34,394, down 85 points and the Nasdaq Composite closed at 14,174, up...

Via Talk Markets

Topics Stocks

Biotechs Ready To Roar ↗

June 13, 2021

The biggest event last week was the FDA decision to approve Biogen's drug aducanumab, a treatment for Alzheimer's disease. The decision will reverberate across the industry and the healthcare sector...

Via Talk Markets

3 Biotech ETFs That Could Double Your Money by 2025 With Zero Effort ↗

June 13, 2021

In a sector where picking individual stocks is a high-risk, high-reward strategy, the diversification of exchange-traded funds can be highly appealing.

Via The Motley Fool

Analyzing SPDR Series Trust SPDR S&P Biotech ETF's Unusual Options Activity ↗

June 11, 2021

SPDR Series Trust SPDR S&P Biotech ETF (NYSE:XBI) shares experienced unusual options activity on Friday. The stock price moved up to $136.19 following the option alert....

Via Benzinga

Topics Stocks

Leisure & Entertainment ETF (PEJ) and AMC Networks (AMCX) Caught In Meme Madness ↗

June 09, 2021

Dynamic Leisure and Entertainment ETF (PEJ) has been by far the best performer over the past week.

Via Talk Markets

Stocks Drop On Turnaround Tuesday As The Next Leg Lower May Have Begun ↗

May 25, 2021

It was not a good day for the Russell 2000. After failing to break out yesterday, it fell sharply today.

Via Talk Markets

Biotech Stocks Cruise Through The Volatility ↗

May 25, 2021

The XLV Healthcare Select SPDR is up 10% YTD.

Via Talk Markets

Medical Miracles Inside Biotech ETFs ↗

May 24, 2021

The events of the past year focused a lot of attention on game changing developments made possible by the global biotech industry. Of the major names Moderna is the one where the original research and...

Via Talk Markets

Topics Intellectual Property

Buy This Instead Of "Big Tech" Stocks And Bank 55% Gains ↗

May 22, 2021

Investors are bobbing laterally from sector to sector, searching for stocks to buy ahead of a traditional summer slowdown that could be made worse by worries about inflation.

Via Talk Markets

5 All-Star ETFs & Stocks to Buy on the Dip ↗

May 19, 2021

Here are the five ETFs that are currently undervalued and could generate solid returns in a rising stock market, and five stocks that are cheap and have the potential to deliver higher returns

Via Talk Markets

How To Profit In A $29 Billion “New Biotech” Sector ↗

May 14, 2021

Drug market companies haven’t exactly hit the S&P 500 yet; we’re still in “ground floor” territory.

Via Talk Markets

Topics Stocks

Biotech ETFs To Suffer As US Backs IP Waiver For COVID-19 Vaccines ↗

May 08, 2021

The Biden administration announced support for the waiver of intellectual property protections for COVID-19 vaccines proposed by South Africa and India. Let’s take a look at ETFs that can suffer from...

Via Talk Markets

Topics Intellectual Property

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.